Up to this date, the vast majority of the SOLACE lung cancer screening sites (14 out of 17) have been actively recruiting participants. More specifically, the project has reached out to over 11,000 female participants, to approximately 3,100 hard-to-reach individuals and to more than 2,600 participants with comorbidities*.
Partners are screening as part of different types of programmes (e.g. pilot trials, randomized controlled trials and national lung cancer screening programmes). The oldest of these programmes has been running since 2020 and the latest began in 2024. The youngest participants can be found in Spain (starting from 40 years upwards) and the oldest in Germany (79 years).
SOLACE is actively looking to reach out to as many people as possible within the targeted population groups. To achieve this goal, it has identified case studies of people who want to share their experience about lung screening with the public. In the upcoming months we hope that even more people will participate in the pilots and we are working on making this happen!
* Individuals are being included within each of the four categories in hard to reach and comorbidities. Upon delivery of the individualized data from sites, the overlapping of these subgroups will be evaluated.
This project is co-funded under the EU4Health Programme 2021–2027 under grant agreement no. 101101187. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
